11/10/2011 - 2:53pm

Genzyme has named leaders of two units that are part of the core focus of the drug maker's business.

11/10/2011 - 2:41pm

AstraZeneca and Targacept released results of the first of four phase-3 clinical trials that investigated the efficacy and tolerability of a drug that could serve as an adjunct therapy to major depressive disorder patients that had an inadequate response to initial antidepressant therapies.

11/10/2011 - 2:30pm

The Food and Drug Administration has accepted a new drug application for a skin cancer treatment developed by Roche.

11/10/2011 - 11:08am

Employers and consumers alike are adopting health savings accounts as a viable way to manage their healthcare costs without compromising care, according to two national surveys released Thursday.

11/10/2011 - 10:40am

Biotechnology company Signum Biosciences has entered a collaborative agreement with GlaxoSmithKline whereby GSK will receive the exclusive right to Signum's proprietary phosphatase screening technology.

11/09/2011 - 2:24pm

According to the most recent consumer snapshot survey by Interclick, 42% of Americans are planning to be immunized this year.

11/09/2011 - 11:24am

Salix Pharmaceuticals has entered a definitive agreement to acquire all outstanding stock of a provider of gastroenterology and urology therapeutics.

11/09/2011 - 11:23am

Generic drug maker Mylan has bought rights to a drug delivery platform made by Pfizer that will allow it to make generic versions of two GlaxoSmithKline respiratory drugs, Mylan said Wednesday.

11/08/2011 - 3:33pm

Purdue Pharma has launched a new way for fighting pharmacy crime, the drug maker said Tuesday.